Editors: Atta-ur-Rahman , Khurshid Zaman

Topics in Anti-Cancer Research

Volume 8

eBook: US $89 Special Offer (PDF + Printed Copy): US $163
Printed Copy: US $119
Library License: US $356
ISSN: 2468-5860 (Print)
ISSN: 2213-3585 (Online)
ISBN: 978-981-14-0437-5 (Print)
ISBN: 978-981-14-0438-2 (Online)
Year of Publication: 2019
DOI: 10.2174/97898114043821190801

Introduction

Topics in Anti-Cancer Research new developments in the field of Cancer. Novel drugs as anticancer agents and antimyeloma for the treatment of different types of cancer including myeloma with distinctive mechanism of action.

The current book series deals with the advances of new drugs and new patented targets, agents and synthetic compounds, which will lead to more effective therapies in cancer patients. Recent patent literature reveals the role of estrogen as endocrine disruptor through inhibition of the AF1 Domain of liganded and unliganded Estrogen Receptors (ERs).

Natural and potent synthetic phenazines patent derivatives with substituent groups i.e. alkyl, amide, carboxylic acid, aldehyde, and pyrano groups show potent anticancer activities.

The potential role of ShcA proteins in stimulating metastasis and advancement of cancer will offer the new tools for cancer therapy. New approaches and challenges for cancer stem cell aiming at cancer therapy is included in this volume.

The anti-tumor activity of mono Bcl-2 inhibitors and Bcl-2 inhibitors in combination with rapologs will be a novel beneficial invention for the cure of advanced Renal Cell Carcinoma (RCC) as well as other cancer.

The diversity of researches and topics published in this eBook Series will be valuable for cancer researchers, clinicians and cancer professional’s aiming to develop new anti-cancer targets and patents for the treatment of various cancers.

The topics covered in the Eighth Volume of this series comprise:

  • - Novel Drugs for Multiple Myeloma
  • - Synthetic Estrogens are Endocrine Disruptors via an Inhibition of the AF1 Domain of ERs
  • - Recent Progress of Phenazines as Anticancer Agents
  • - ShcA family of adaptor proteins: role in metastasis and cancer progression
  • - Cancer stem cell targeting for anticancer therapy: Strategies and challenges

Contributors

Editor(s):
Atta-ur-Rahman FRS
Honorary Life Fellow
Kings College
University of Cambridge
UK


Khurshid Zaman
Bentham Science Publishers
USA




Contributor(s):
Ghulam Abbas
Department of Biological Sciences and Chemistry
University of Nizwa
Nizwa
Oman Email: abbashej@unizwa.edu.om


Ivan R. Green
Department of Chemistry and Polymer Science
University of Stellenbosch
Stellenbosch
South Africa Email: irg@sun.ac.za


Hidayat Hussain
Department of Bioorganic Chemistry
Leibniz Institute of Plant Biochemistry
Halle (Saale)
Germany Email: hussainchem3@gmail.com


Amjad Khan
Boyle & Hooke Oxford
Hampden House
Oxford
UK Email: amjadkhan2002@hotmail.com


Khanzadi F. Khattak
Department of Chemistry
Women University
Swabi
Pakistan Email: khattakkf@yahoo.com


Najeeb Ur Rehman
Natural and Medical Sciences Research Center
University of Nizwa
Nizwa
Oman Email: najeeb@unizwa.edu.om


Pawel Robak
Department of Experimental Hematology
Medical University of Lodz
Lodz
Poland Email: robakpawel@op.pl


Tadeusz Robak
Department of Hematology
Medical University of Lodz
Lodz
Poland Email: robaktad@csk.umed.lodz.pl


Zsuzsanna Suba
Department of Molecular Pathology
National Institute of Oncology
Budapest
Hungary Email: subazdr@gmail.com




RELATED BOOKS

.Advances in Cancer Nanotheranostics for Experimental and Personalized Medicine.
.Current Advances in Breast Cancer Research: A Molecular Approach.
.Avastin and Malignant Gliomas .
.Cutting Edge Therapies for Cancer in the 21 Century.